Drug intelligence / Profile preview

AI500

Development stage
Unknown
Lead developer
C. Contrad Swiss
Modality
Hydrogel Systems → Drug Delivery Systems, Recombinant Proteins and Enzymes
Administration
Topical
01

Overview

AI500 is a **topical medical device** formulated as a monodose hydrogel for direct skin application, used to relieve pain caused by the inflammatory response in muscles, joints, and adjacent tissues to improve movement and function[1][3]. The gel contains **SH-Polypeptide-6**, a recombinant peptide derived from Interleukin-10 (IL-10), embedded in **hyaluronic acid**. SH-Polypeptide-6 mimics the anti-inflammatory activity of IL-10 by modulating NF-kB signaling and downregulating pro-inflammatory cytokines (TNF, IL-6, IL-1, IL-8), thus reducing pain and inflammation. Additionally, it inhibits protein tyrosine phosphatase 1B, potentially alleviating muscle pain and spasms. Unlike IL-10, SH-Polypeptide-6 provides rapid tissue bioavailability at the application site. AI500 is indicated for acute and chronic knee pain and musculoskeletal conditions, with clinical data supporting pain relief and improved function in patients with osteoarthritis and other knee problems. The product is non-invasive, applied via a patch, and demonstrates a favorable safety profile with minimal adverse events[3].

Brand names
AI500AI-500AI 500
Other names
AI500®AI500^®^
02

Targets

IL8 (C-X-C Motif Chemokine Ligand 8)PTPN1 (Protein tyrosine phosphatase 1B)IL1A (Interleukin 1 alpha)TNFA (Tumor necrosis factor alpha (soluble))IL-6 (Interleukin 6)

Beyond the preview

Go deeper on AI500.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AI500.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call